AtriCure, Inc.
ATRC
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surā¦ read more
Healthcare
Medical Instruments & Supplies
20 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$37.76
Price-5.95%
-$2.39
1Y
Price
Market Cap
$1.921b
Small
Price/Earnings 3y Avg5y Avg
1,172.7x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+6.0%
EBITDA Margin-0.2%
Net Profit Margin+18.0%
Free Cash Flow Margin+6.0%
EBITDA Margin-0.2%
Net Profit Margin+18.0%
Free Cash Flow MarginRevenue
$569.622m
+11.4%
1y CAGR+16.3%
3y CAGR+17.3%
5y CAGREarnings
$10.552m
+35.6%
1y CAGR+7.8%
3y CAGR-42.3%
5y CAGREPS
$0.21
+35.8%
1y CAGR+9.1%
3y CAGR-41.6%
5y CAGRBook Value
$516.433m
$676.643m
Assets$160.210m
Liabilities$71.048m
DebtDebt to Assets
10.5%
-12.3x
Debt to EBITDAFree Cash Flow
$58.114m
+242.2%
1y CAGR+105.4%
3y CAGR+62.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company